glp 1 new drug Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a study finds World Health Organization recommends GLP-1
Description
Future research should prioritize the development of next-generation agonists, explore combination therapies, and integrate precision medicine approaches to optimize patient outcomes
GLP-1 agonists and GIP antagonists GIP antagonism is also a potential obesity treatment as in preclinical studies improved the metabolic profile and reduced food intake [54,55,56]
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons
Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L
